Back to Search
Start Over
Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma.
- Source :
-
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Nov; Vol. 20 (11), pp. 774-776. Date of Electronic Publication: 2020 Aug 22. - Publication Year :
- 2020
- Subjects :
- Antibodies, Neutralizing immunology
Antibodies, Viral immunology
Betacoronavirus isolation & purification
COVID-19
Chronic Disease
Coronavirus Infections blood
Coronavirus Infections complications
Coronavirus Infections diagnosis
Female
Humans
Lung diagnostic imaging
Lymphoma, Follicular complications
Lymphoma, Follicular drug therapy
Lymphoma, Follicular immunology
Middle Aged
Pandemics
Pneumonia, Viral blood
Pneumonia, Viral complications
Pneumonia, Viral diagnosis
SARS-CoV-2
Tomography, X-Ray Computed
Antibodies, Neutralizing blood
Antibodies, Viral blood
Antineoplastic Agents, Immunological adverse effects
Betacoronavirus immunology
Coronavirus Infections immunology
Pneumonia, Viral immunology
Rituximab adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 2152-2669
- Volume :
- 20
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Clinical lymphoma, myeloma & leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 32933879
- Full Text :
- https://doi.org/10.1016/j.clml.2020.08.017